By last winter, medetomidine was showing up in 70% of illicit opioid samples tested in Philly, along with other unregulated ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

Withdrawal is a constellation of aversive symptoms—ranging from anxiety, tremors (“the shakes”), and nausea to hallucinations and frank seizures—brought on by the sudden stoppage or dosage drop of ...

A new device is being used by addiction treatment programs and in detention centers to help addicts get through opiate ...